Popular Articles
Grapefruit Benefits

Economic Crisis Already Crippling Global HIV/AIDS Treatment, Prevention Programs, UNAIDS, World Bank Report Says
Global HIV/AIDS prevention and treatment programs are already feeling the effects of the global economic crisis, according to a report (pdf) released Monday by UNAIDS and the World Bank, AFP/Google.com reports (7/6).
generic viagra online
Latin America Must Cut Blood Pressure To Thrive
Combating high blood pressure is a global challenge. But while developed countries have enjoyed reductions in cardiovascular disease over recent decades, Latin America has been less fortunate. In fact new research published in the journal Therapeutic Advances in Cardiovascular Disease shows that high blood pressure is on the increase in many Latin American countries, a situation set to worsen unless immediate action is taken.
News of the day
Health Officials Issue Revised Pregnancy Weight-Gain Guidelines For Obese Women
The Institute of Medicine and the National Research Council on Thursday issued revised U.S. weight-gain guidelines for obese pregnant women, in response to rising levels of obesity in the country and growing evidence that weight gain can cause health problems for women and their infants, the New York Times reports. The revision, which is the first since 1990, recommends that obese women -- those with a body mass index of 30 or more -- limit their weight gain to 11 to 20 pounds over nine months. The 1990 pregnancy guidelines did not specifically address weight gain for obese women, telling them instead to follow the recommendations for overweight women. According to health officials, the changes to the recommendations for obese women were required to keep up with the changing weight patterns among women in the U.S. The New York Times reports that about 27% of women of childbearing age are considered obese, while 55% fall into the categories of overweight or obese.The recommendations for women with BMIs of less than 30 did not change. They call for overweight women -- those with a BMI of 25 to 29.9 -- to gain 15 to 25 pounds over nine months, while underweight women -- with BMIs of less than 18.5 -- should gain 28 to 40 pounds, and normal-weight women -- with BMIs of 18.6 to 24.9 -- should gain 25 to 35 pounds (Parker-Pope, New York Times, 5/29).Time reports that pregnant women who do not gain enough weight face a higher risk of stunted fetal growth and preterm delivery. However, it is more common for women to gain too much weight, placing them at higher risk for conditions like gestational diabetes and high blood pressure. In addition, their infants are at increased risk of being born earlier, larger and by cesarean section. Time reports that excessive weight gain can increase a woman"s risk of postpartum obesity and elevate risks of heart disease and stroke because most women do not lose extra pounds gained during pregnancy. Many studies also have suggested that a woman"s gestational weight can predict potential weight problems in her offspring (Kingsbury, Time, 5/28).The committee that developed and issued the revision said that the existing guidelines were essentially on target but that women and their physicians need to work harder to help women reach a normal weight before pregnancy and avoid gaining too much weight during pregnancy, according to the Los Angeles Times (Roan, Los Angeles Times, 5/29). The guidelines also recommend more nutrition and exercise counseling during pregnancy, advising physicians or midwives to consult dieticians to shape a woman"s care regardless of her initial weight, the AP/Yahoo! News reports (Neergaard, AP/Yahoo! News, 5/28). The Los Angeles Times reports that health care professionals are expected to recognize and implement some of the recommendations; however, it is not mandatory to do so.Several experts on maternal obesity and child health expressed disappointment with the guidelines, arguing that obese women should gain little to no weight during pregnancy, according to the Los Angeles Times. They also argue the new guidelines do not do enough to address obesity before pregnancy. Maxine Hayes, state health officer for the Washington State Department of Health, said, "If we wait for every woman to be advised about weight gain after they become pregnant, it"s too late. It puts women and their babies on a trajectory that is unhealthy" (Los Angeles Times, 5/29).
Nutrition

Depression Medications May Reduce Male Fertility

As many as half of all men taking the antidepressant medication paroxetine (trade names Seroxat, Paxil) may have increased sperm DNA fragmentation -- a predictor of compromised fertility. Research led by NewYork-Presbyterian Hospital/Weill Cornell Medical Center also found that the changes are reversible with normal levels of sperm returning after discontinuation of the drug. The study is currently published in the online edition of the journal Fertility & Sterility, and represents one of the first scientific investigations into the effect of antidepressants on sperm quality. "It"s fairly well known that SSRI antidepressants negatively impact erectile function and ejaculation. This study goes one step further, demonstrating that they can cause a major increase in genetic damage to sperm," says Dr. Peter Schlegel, the study"s senior author. "Although this study doesn"t look directly at fertility, we can infer that as many as half of men taking SSRIs have a reduced ability to conceive. These men should talk with their physician about their treatment options, including non-SSRI depression medications." Dr. Schlegel is chairman of the Department of Urology and professor of reproductive medicine at Weill Cornell Medical College, and urologist-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The study followed 35 healthy male volunteers who were given paroxetine, a selective serotonin reuptake inhibitor (SSRI), for five weeks. The drug was used because of its relatively short half-life and because it has previously shown to exert the strongest effect in delaying ejaculation. DNA fragmentation, defined as missing pieces of genetic code in the sperm DNA, was measured using an assay called deoxyuride-50-triphosphate biotin nick end labeling (TUNEL). Results showed that the percent of participants with abnormal DNA fragmentation rose from less than 10 percent to 50 percent while taking the drug. DNA fragmentation, the authors note, is known to correlate with poorer fertility and pregnancy outcomes, even when techniques such as in vitro fertilization and intracytoplasmic sperm injection are applied. It has also been linked with an increased risk for birth defects. The study also confirmed the effect of SSRIs on sexual function, with more than a third of study participants reporting significant changes in erectile function and almost half reporting ejaculatory difficulties. Normal levels of both sexual function and DNA fragmentation returned one month after discontinuation of the drug. Sperm volume, concentration, motility and morphology were not significantly changed by SSRI therapy -- although previous research by the NewYork-Presbyterian/Weill Cornell team has shown SSRIs to affect these measures in some men. What accounts for these findings -- more specifically, how does the drug affect the sperm? Lead author Dr. Cigdem (Cori) Tanrikut explains that while the exact mechanism isn"t understood, the evidence points to the drug slowing sperm as it travels through the male reproductive tract from the testis to the ejaculatory ducts. Sperm gets "hung up," she says, allowing it to get old and its DNA damaged. "Our main clue is that DNA integrity was quickly restored once the study participants stopped taking the drug. This would have taken much longer had sperm production been affected," says Dr. Tanrikut, who is affiliated with Massachusetts General Hospital and Harvard Medical School, and led the study while completing a fellowship in male reproductive medicine and microsurgery at NewYork-Presbyterian/Weill Cornell. She is currently adjunct assistant professor of urology and reproductive medicine at Weill Cornell Medical College. "This is a new concept for how drugs can affect fertility and sperm," notes Dr. Schlegel. "In most cases, it was previously assumed that a drug damaged sperm production, so the concept that sperm transport could be affected is novel." "An estimated half of all infertility is related to problems on the man"s side," continues Dr. Schlegel. "It is our hope that this research can improve couples" chances for conception, and potentially better our ability to create drugs that won"t get in the way." Co-authors included Drs. Margaret Altemus and Darius A. Paduch of NewYork-Presbyterian/Weill Cornell; and Dr. Adam S. Feldman of Massachusetts General Hospital and Harvard Medical School. The study was supported with help from the Frederick and Theresa Dow Wallace Fund of the New York Community Trust. Depression affects approximately 10 percent of American men over their lifetimes. Antidepressant medications are the most common form of treatment, with almost 233 million prescriptions written in 2007. The most common drug therapy used are selective serotonin reuptake inhibitors (SSRIs). While the current study looked at healthy, non-depressed individuals, it is known that untreated depression or anxiety alone can affect fertility. Recent research has shown that for both pregnant women with untreated major depression and for those who were taking SSRIs throughout their pregnancy, more than 20 percent of infants were delivered preterm. NewYork-Presbyterian Hospital/Weill Cornell Medical Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):